This meta-analysis attempted to derive pooled estimates for the putative association between echocardiographic or electrocardiographic left ventricular hypertrophy and the deletion/insertion (D/I) polymorphism of the angiotensin-I converting enzyme. Casecontrol studies were combined, using the Mantel and Haenszel approach. Joint P-values for continuous variables were calculated by Stouffer's method. Continuous measurements of left ventricular mass, which were reported in different units, were expressed on a percentage scale using the within-study mean of the II genotype as the denominator. The computerised database used for this analysis, included 28 reports with an overall sample size of 6638 subjects. The prevalence of the D allele was significantly lower in Japanese (37.2%) than in Caucasians (56.2%). A funnel plot including 12 casecontrol studies (4094 subjects) suggested that no publication bias was present. Overall, left ventricular hypertrophy was not associated with the D allele. Compared with the II genotype, the excess risks of left ventricular hypertrophy associated with DD and DI geno-
Introduction
Cloning of the human angiotensin-converting enzyme (ACE) gene has led to the discovery of a polymorphism, consisting of either the absence (deletion, D) or presence (insertion, I) of a 287-base pair DNA fragment inside intron 16. 1,2 Early studies demonstrated a strong correlation between the D allele and the circulating 1, 3 and intralymphocytic 4 levels of ACE. Compared with the II genotype, the ACE activity was highest in DD homozygotes and intermediate in DI heterozygotes. There is accumu-lating evidence that several cardiovascular-renal diseases, such as myocardial infarction and diabetic nephropathy, are associated with the D/I polymorphism of the ACE gene, whereas hypertension is not. 5 However, whether or not the D/I ACE polymorphism is associated with left ventricular hypertrophy, especially in hypertension, remains disputed. In the present meta-analysis of case-control and cross-sectional studies in humans, we attempted to resolve part of the controversy in the published literature by deriving pooled estimates for the association between left ventricular hypertrophy and the D/I polymorphism of the ACE gene.
Methods

Literature search and data extraction
As described in detail in previous articles, 5, 6 eligible studies were traced by electronic Medline searches, via reference lists of published articles and via the tables of contents of the major medical journals published before January 1999. Several experts in the field were contacted in order to ascertain that important unpublished datasets with null outcome and relevant published articles had not been omitted from the meta-analysis. These studies were then examined for their methodological quality as casecontrol or cross-sectional studies.
For all groups included in the analysis, three investigators (JAS, TK, JGW), working independently, attempted to retrieve and tabulate the following information: definition and presence of left ventricular hypertrophy, race, sex, average age, hypertensive status, antihypertensive treatment. The reviewers also searched the publications for the average left ventricular mass (index) or left ventricular wall thickness associated with each genotype. Whenever possible, these results were extracted separately for men and women and subjects of different racial origin. Race, sex, the impact factor of the journals in which the papers had been published and the methodology of ACE genotyping were also considered in the sensitivity analysis.
If all of the above-mentioned information could not be extracted or calculated from the published articles, the authors were contacted in writing in order to collect the missing data. The allele and genotype frequencies were extracted whenever possible, but in some cases, the prevalence of the alleles or genotypes 7, 8 or the allele frequencies were calculated by applying the Hardy-Weinberg principle, 9 as reflected by the formula p 2 + 2pq + q 2 = 1. Furthermore, the present meta-analysis required the use of parametric statistics to obtain pooled estimates for continuous measurements, such as left ventricular mass (index). In order to make use of a few results reported in non-parametric format, the median was assumed to approximate to the mean, the range and the 5th to 95th percentile interval to four times the standard deviation and the interquartile range (25th to 75th percentile interval) to twice the standard deviation.
Statistical analyses
The data retrieved from the reviewed articles were computerised and analysed, using SAS software (SAS Institute Inc, Cary, NC, USA). The 2 -statistic was used to compare the allelic frequencies between races.
Case-control studies were combined, using the Mantel and Haenszel approach. 10 The hypothesis of homogeneity of the odds ratios across 2 × 2 contingency tables was investigated by Breslow and Day's test. 11 To search for publication bias among the casecontrol studies, the natural logarithm of each study's odds ratio was plotted against the logarithm of its sample size. 12 For continuous measurements reported in different units the within-study mean of the II genotype was used as the denominator to rescale the values of the other genotypes on a percentage scale. Association sizes were assessed from the percentage differences in left ventricular mass (index) between the DD and DI genotypes and the II reference group. Joint values of P were calculated by Stouffer's method, as modified by Mosteller and Bush. 13 The sensitivity of the findings was examined by recalculating the pooled association sizes and joint values of P in homogeneous subgroups.
Results
Computerised database
A total of 28 studies on the association between the D/I polymorphism and left ventricular hypertrophy were found and entered into a computerised database for the present analysis. 7,8,14 -39 Of the 28 reports, three were only available in abstract format 19, 20, 33 and one study was a personal communication. The total sample size of all 28 studies combined was 6638 subjects.
Prevalence of the D allele
In accordance with previous findings, 23 the overall prevalence of the D allele was 52.8%. The DD, DI and II genotypic frequencies were 28.6%, 48.3% and 23.1%, respectively. In all studies combined, the DD genotypic frequencies were 3-4% higher than would be expected according to the Hardy-Weinberg equilibrium, 9 whereas the DI frequency was 4% lower. The prevalence of the D allele was significantly lower (P Ͻ 0.001) in Japanese (37.2%) than in Caucasians (56.2%).
Methodological assessment of the case-control studies
In 12 case-control studies, 7,8,14 -17,21,32,36-39 patients with left ventricular hypertrophy and control subjects were selected from one of the following sampling frames (Table 1) : the general population, 14, 16, 17, 39 hypertensive patients examined at the out-patient clinic, 15, 21, 36 hospitalised patients with hypertension 7, 8, 38 or renal insufficiency, 37 or men in military service. 32 The definition of left ventricular hypertrophy varied widely among the 12 studies (Table 1) . Three studies used ECG criteria to define left ventricular hypertrophy. 14, 15, 32 In two studies, the diagnosis was based on the Sokolov-Lyon index (SV1 + RV5 or V6 у3.5 mV) combined or not with Minnesota code 3.1. (RV5, V6 Ͼ2.6 mV or R I, II, III, aVF у20 mV or RaVL Ͼ12 mV) or the Rautaharju criterion.
14,32 One study applied the point score system generated by the Marquette Software (Marquette Electronics, Inc, Milwaukee, WI, USA). 15 In nine studies, the presence or absence of left ventricular hypertrophy was diagnosed by echocardiographic criteria. Sexspecific population-based echocardiographic thresholds derived from healthy reference samples (Framingham and Novosibirsk) were applied in three studies. 16, 17, 39 In two studies 21, 36 the American Society of Echocardiography and Penn convention criteria served to define left ventricular hypertrophy. Depending on the formula applied, the cut-off values for left ventricular hypertrophy ranged from in women. The 12 case-control studies included 16 groups of which the characteristics are summarised in Table  2 . With the exception of two studies in Japanese 15, 37 and one American study 21 which included 25% of blacks, only whites were studied. 8, 14, 16, 17, 32, 36, 38, 39 Of 16 groups, five included only men, 14, 16, 32, 39 two included only women, 14, 16 and eight had a mixed sex composition. 7, 8, 15, 17, 21, [36] [37] [38] The sex ratio was not given for cases and controls in five reports. 7, 8, 15, 37, 38 Average age ranged from 18.9 32 to 61 7 years. In several studies it was impossible to evaluate whether cases and controls had been properly matched according to sex, age, body mass index, duration and severity of hypertension (Table 2) .
Method for DNA analysis ACE genotyping may rely on the plain amplification of DNA 1,2 or on the amplification in the presence of 5% dimethyl sulphoxide (DMSO) 40, 41 and/or insertion-specific primers. 42 Studies in which specific primers had been used 16, 17, 21, 37 were contrasted with the remainder of the reports. 7, 8, 14, 15, 32, 36, 38, 39 Odds of left ventricular hypertrophy associated with the D-allele In the first step of the analysis, allele frequencies were calculated (Table 3) . Among cases and con- (Table 3) . Only in three groups, 14, 15, 36 a statistically significant association between the D allele and left ventricular hypertrophy could be detected. When all groups were pooled, the overall association was 1.09 (95% CI: 0.98 to 1.21; P = 0.12). However, across three studies, 15, 21, 36 which included only untreated hypertensive patients, the odds ratio was 1.61 (95% CI: 1.15 to 2.26; P = 0.004).
Odds of left ventricular hypertrophy associated with the DD and DI genotypes
In 12 studies (4094 subjects) the pooled excess risk of left ventricular hypertrophy associated with DD genotype, compared with the II genotype, did not attain statistical significance; it was only 14% (95% CI: 0.92 to 1.42; P = 0.23). The risk associated with the DI genotype was 5% (95% CI: 0.87 to 1.28; P = 0.61).
Breslow-Day's test (P = 0.02) suggested that there was significant heterogeneity among the studies. The sensitivity analysis ( tensive subjects, normotensive subjects, 14, 17, 32, 39 and groups who had been genotyped using DNA amplification in the absence 7, 8, 14, 15, 32, 36, 38, 39 or the presence 16, 17, 21, 37 of insertion-specific primers. 42 No study included only blacks or women (Table 4) . In untreated hypertensive patients, 15, 21, 36 DD homozygozity was associated with a 192% (P = 0.002) higher risk of left ventricular hypertrophy than that observed in the II reference group. This was not the case in treated hypertensive patients, in whom the odds ratio associated with the DD genotype was 1.45 (95% CI: 0.66 to 3.18; P = 0.35). 14, 38, 39 In studies in which the subjects had been genotyped using DNA amplification in the absence of insertion-specific primers, 7, 8, 14, 15, 32, 36, 38, 39 DD homozygozity was associated with a 50% higher risk of left ventricular hypertrophy (95% CI: 1.09 to 2.05; P = 0.01). However, the outcome of the sensitivity analysis exploring the possible influence of the technique of genotyping was heavily influenced by two large studies, one with positive results which applied plain DNA amplification 14 and one with negative results in which a I-specific primer was used. 16 Further sensitivity analyses in all other homogeneous groups did not reveal any significant association between left ventricular hypertrophy and the ACE genotype (Table 4) .
Publication bias
The funnel plot 12 searching for publication bias among the case-control studies did not reveal a deficit of small studies with negative results, sugJournal of Human Hypertension gesting that overall there was no publication bias ( Figure 1) .
The median impact factor of the journals in which the case-control studies had been published was 3.3 (range: 0.09 to 22.7). If the studies published in journals with an impact factor 43 of at least four were combined (Table 4) , the odds ratios for the DD versus the II genotype was 1.20 (95% CI: 0.94 to 1.54; P = 0.14; n = 3407). 14 -16,32,36 Thus, publications in reputable journals led to similar conclusions as those in other periodicals. 
Left ventricular mass as a continuous trait
For the continuous outcome variables the z-scores of the groups included in the meta-analysis represented a continuum with no evidence for a bimodal or other distribution. Thus, for the continuous variables the hypothesis of homogeneity was not rejected.
Left ventricular mass (index) or left ventricular wall thickness were reported by genotype in 23 cross-sectional studies (5438 subjects). [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [33] [34] [35] [36] [37] 39 The pooled relative differences with the II reference group averaged only 3.3% (95% CI: −139 to 146%, P = 0.52) for DD homozygotes and 0.8% (95% CI: −11.9 to 13.4%, P = 0.54) for DI homozygotes ( Figure  2 ). However, in DD homozygotes who had never been treated for hypertension, echocardiographic left ventricular mass (index) was on average 10.1% (95% CI: 4.8 to 15.5%, P = 0.001) higher than in untreated II homozygotes. Among the untreated subjects nearly 80% had been genotyped in the absence of I-specific primers.
Discussion
We did not observe an overall association between left ventricular hypertrophy and the D variant of the ACE gene, regardless of whether we pooled casecontrol or association studies and regardless of whether we investigated the risk associated with the D allele or that associated with the DD and DI genotypes. Indeed, compared with II homozygotes, DD and DI subjects had excess risks of left ventricular hypertrophy of only 14% and 5%, respectively, which were far from statistical significant. Moreover, in terms of allele frequencies, the common odds ratio associated with the D allele, compared with the I variant, was only 1.09.
The present review includes studies based not only on echocardiography, but also on electrocardiography, which is easier to standardise. To pool these studies we rescaled between-genotype differences in echocardiographic and electrocardiographic left ventricular mass on a percentage scale. The absence of an overall association between left ventricular hypertrophy and the D/I polymorphism must be cautiously interpreted, because the pooled results of a quantitative overview critically depend on the quality and the homogeneity of the studies reviewed. 44 Studies included in an overview must be scrutinised for sample size and statistical power, for the accuracy with which cases and controls were matched, and for factors, which may explain positive or negative findings. Along these lines, only 16 of 28 reviewed studies had a sample size of more than 100 subjects. 7,8,14 -16,18,19,25-29,32,33,36,39 Left ventricular mass is a continuous variable, under the influence of a large number of environmental factors and other determinants, such as age, sex, race, body mass index, blood pressure and various hormonal and neurogenic stimuli. 45 Moreover, echocardiography is difficult to standardise and prone to pitfalls in the execution of the technique. Large interindividual variability and measurement error may explain why even for all studies combined the sample size may still have been too small to detect a statistically significant association. Furthermore, in several studies, cases and controls were not well matched, for instance with regard to the proportion of hypertensive patients among the cases and controls. 7, 8 Heterogeneity among the reviewed studies is another problem potentially limiting the interpretation of pooled risk estimates. In the present analysis we found significant heterogeneity among the case-control studies. Diversity among the groups studied may obscure a relationship, but on the other hand, may also help to highlight factors which modulate it. Indeed, the present sensitivity analysis revealed that among untreated hypertensive subjects a significant association was present between left ventricular hypertrophy and the D/I polymorphism; compared with the II reference group, DD homozygotes and DI heterozygotes had a two to three times higher risk.
The association between left ventricular hypertrophy and the DD genotype was significant in studies based on the plain amplification of DNA in the presence or the absence of 5% dimethyl sulphoxide (DMSO), 7, 8, 14, 15, 32, 36, 38, 39 but not in those in which Ispecific primers had been used. 16, 17, 21, 37 Over-representation of the D-allele in the former studies would rather obscure than strengthen the possible relation between left ventricular hypertrophy and the D/I polymorphism. Thus, the absence of an association in the studies which used I-specific primers, must have been due to confounding factors, such as the inclusion of treated hypertensive patients recruited either from the out-patient clinic 37 or from the general population, 16 or to the enrolment of normotensive subjects, 17 whose blood pressure was too low to cause left ventricular enlargement.
There was no evidence for publication bias. Indeed, the funnel plot did not reveal a deficit of publication of smaller studies with negative findings. The hypothesis that positive studies were mainly published in journals with a high impact factor was also not confirmed.
The hypothesis that polymorphism of the ACE gene may play a role in the development of left ventricular hypertrophy is plausible. First, there is mounting evidence that increased ACE gene expression and ACE activity may stimulate the local rate of angiotensin II production [46] [47] [48] [49] and, in turn, may promote cardiac growth. Second, the D variant of the ACE gene may act only under specific conditions, when physiologic or pathophysiologic processes stimulate left ventricular enlargement. 50 In agreement with this concept is the observation 32 that in young healthy subjects exercise training increased echocardiographic and electrocardiographic left ventricular mass in carriers of the D allele. Moreover, the present sensitivity analysis suggested that left ventricular hypertrophy is only associated with the DD genotype in hypertensive subjects, in whom the effect of the augmented blood pressure is not opposed by antihypertensive drug treatment.
The diagnosis of left ventricular hypertrophy involves the dichotomization of subjects in those with and those without the disorder, using arbitrary and widely different threshold values. This may have greatly reduced the power of the case-control studies to detect a relation between left ventricular enlargement and the D allele. Considering left ventricular mass as a quantitative trait may constitute a more informative approach. Nevertheless, in all available association studies in which left ventricular mass was analysed as a continuous trait, no association was detected. Only when untreated hypertensive subjects were analysed separately, the pooled association between left ventricular mass and the D allele was significant, confirming the results of the sensitivity analysis of the case-control studies. Thus, the D allele probably behaves as a marker for left ventricular enlargement if a pathophysiologic process causing this disorder, remains unopposed by treatment.
